Precision medicine: from science to value
GS Ginsburg, KA Phillips - Health affairs, 2018 - healthaffairs.org
Precision medicine is making an impact on patients, health care delivery systems, and
research participants in ways that were only imagined fifteen years ago when the human …
research participants in ways that were only imagined fifteen years ago when the human …
[HTML][HTML] Personalized medicine and the power of electronic health records
NS Abul-Husn, EE Kenny - Cell, 2019 - cell.com
Personalized medicine has largely been enabled by the integration of genomic and other
data with electronic health records (EHRs) in the United States and elsewhere. Increased …
data with electronic health records (EHRs) in the United States and elsewhere. Increased …
[HTML][HTML] GA4GH: International policies and standards for data sharing across genomic research and healthcare
Summary The Global Alliance for Genomics and Health (GA4GH) aims to accelerate
biomedical advances by enabling the responsible sharing of clinical and genomic data …
biomedical advances by enabling the responsible sharing of clinical and genomic data …
Artificial intelligence and personalized medicine
NJ Schork - Precision medicine in Cancer therapy, 2019 - Springer
The development of high-throughput, data-intensive biomedical research assays and
technologies has created a need for researchers to develop strategies for analyzing …
technologies has created a need for researchers to develop strategies for analyzing …
Exome sequencing–based screening for BRCA1/2 expected pathogenic variants among adult biobank participants
Importance Detection of disease-associated variants in theBRCA1andBRCA2 (BRCA1/2)
genes allows for cancer prevention and early diagnosis in high-risk individuals. Objectives …
genes allows for cancer prevention and early diagnosis in high-risk individuals. Objectives …
[HTML][HTML] Clinical outcomes of a genomic screening program for actionable genetic conditions
Purpose Three genetic conditions—hereditary breast and ovarian cancer syndrome, Lynch
syndrome, and familial hypercholesterolemia—have tier 1 evidence for interventions that …
syndrome, and familial hypercholesterolemia—have tier 1 evidence for interventions that …
[HTML][HTML] A model for genome-first care: returning secondary genomic findings to participants and their healthcare providers in a large research cohort
MLB Schwartz, CZ McCormick, AL Lazzeri… - The American Journal of …, 2018 - cell.com
There is growing interest in communicating clinically relevant DNA sequence findings to
research participants who join projects with a primary research goal other than the clinical …
research participants who join projects with a primary research goal other than the clinical …
[HTML][HTML] Quantifying the polygenic contribution to variable expressivity in eleven rare genetic disorders
Rare genetic disorders (RGDs) often exhibit significant clinical variability among affected
individuals, a disease characteristic termed variable expressivity. Recently, the aggregate …
individuals, a disease characteristic termed variable expressivity. Recently, the aggregate …
Opportunities, resources, and techniques for implementing genomics in clinical care
TA Manolio, R Rowley, MS Williams, D Roden… - The Lancet, 2019 - thelancet.com
Advances in technologies for assessing genomic variation and an increasing understanding
of the effects of genomic variants on health and disease are driving the transition of …
of the effects of genomic variants on health and disease are driving the transition of …
Testing and management of iron overload after genetic screening–identified hemochromatosis
JM Savatt, A Johns, MLB Schwartz… - JAMA Network …, 2023 - jamanetwork.com
Importance HFEgene–associated hereditary hemochromatosis type 1 (HH1) is
underdiagnosed, resulting in missed opportunities for preventing morbidity and mortality …
underdiagnosed, resulting in missed opportunities for preventing morbidity and mortality …